1q41q42 microdeletion syndrome

1q41q42 microdeletion syndrome (also known as 1q41-q42 deletion syndrome or chromosome 1q41-q42 deletion syndrome) is a rare chromosomal disorder caused by a submicroscopic deletion on the long arm of chromosome 1, in the region spanning bands q41 to q42. This condition arises from the loss of genetic material (microdeletion) and typically occurs as a de novo event, meaning it is not inherited from either parent in most cases. The syndrome affects multiple body systems, including the central nervous system, musculoskeletal system, and craniofacial structures. Key clinical features include intellectual disability of variable severity, global developmental delay, seizures or epilepsy, and speech and language impairment. Affected individuals frequently present with distinctive craniofacial features such as a broad or prominent forehead, widely spaced eyes (hypertelorism), a short nose with a broad nasal bridge, thin upper lip, and micrognathia (small jaw). Additional findings may include corpus callosum abnormalities or other structural brain malformations, clubfoot (talipes equinovarus), cleft palate, and congenital heart defects. Hypotonia (low muscle tone) is commonly observed in infancy. Some patients may also exhibit diaphragmatic hernia and genitourinary anomalies. There is no cure for 1q41q42 microdeletion syndrome, and management is symptomatic and supportive. Treatment typically involves a multidisciplinary approach including early intervention programs, speech therapy, physical therapy, occupational therapy, and antiepileptic medications for seizure control. Surgical intervention may be required for structural anomalies such as congenital heart defects, cleft palate, or diaphragmatic hernia. Regular developmental assessments and monitoring by specialists in neurology, cardiology, and other relevant fields are recommended to optimize outcomes.

Common questions about 1q41q42 microdeletion syndrome